Showing results (1461-1470 of 4,690) with videos related to

Sort By:
Pageof 469
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 8, 2012
Exercise in the community for people with multiple sclerosis--a follow-up of people with minimal gait impairmentMaria Garrett, Neasa Hogan, Aidan Larkin, et al.
Eye (London, England)|July 31, 1998
Distribution of integrins alpha v beta 5, alpha v beta 3 and alpha v in normal human cornea: possible implications in clinical and therapeutic adenoviral infectionS A Rayner, J L Gallop, A J George, et al.
Comprehensive Psychiatry|July 24, 1998
Compliance with neuroleptic medication in outpatients with schizophrenia; relationship to subjective response to neuroleptics; attitudes to medication and insightJ Garavan, S Browne, M Gervin, et al.
Clinical and Translational Science|October 17, 2012
Building communities of practice: the research nurse round tableMary E Larkin, Catherine A Griffith, Linda Pitler, et al.
Physical Therapy|July 1, 1987
Relationship between static muscle strength deficits and spasticity in stroke patients with hemiparesisR W Bohannon, P A Larkin, M B Smith, et al.
Disability and Rehabilitation|February 16, 2026
Accessible decision-making capacity evaluations for patients with aphasia: a quality improvement project to develop, implement, and evaluate an online training module for interdisciplinary healthcare providersElissa Larkin, Julia Carpenter, Shelly Benjaminy, et al.
American Journal of Preventive Medicine|September 5, 2024
Spatial and Temporal Patterns of Chronic Disease Burden in the U.S., 2018-2021Jocelyn V Hunyadi, Kehe Zhang, Qian Xiao, et al.
Limnology and Oceanography|June 20, 2024
Bacterial biogeography of the Indian OceanMelissa L Brock, Alyse A Larkin, Eric J Raes, et al.
Maternal and Child Health Journal|March 11, 2016
Implications of Comprehensive Mental Health Services Embedded in an Adolescent Obstetric Medical HomeBethany Ashby, Nikhil Ranadive, Veronica Alaniz, et al.
ESMO Open|January 28, 2025
Is pathological response an adequate surrogate marker for survival in neoadjuvant therapy with immune checkpoint inhibitors?K Sugiyama, A Gordon, S Popat, et al.
Pageof 469